N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: Results of a prospective, randomized, double-blind study

Critical Care Medicine

Volumn 28, Issue 12, 2000, Pages 3799-3807

  Rank, Nikolaus ^a   Michel, Christian ^a   Haertel, Corina ^a   Med, Cand ^c   Lenhart, Andreas ^a   Welte, Martin ^a   Meier Hellmann, Andreas ^b   Spies, Claudia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c Friedrich Schiller Universität Jena ^*

Author keywords

Difference between arterial and gastric mucosal carbon dioxide tension; Gastric intramucosal pH; Hepatosplanchnic blood flow; Indocyanine green; Intensive care unit; Monoethylglycinexylidide; N acetylcysteine; Patients; Regional oxygen consumption; Regional oxygen delivery; Septic shock; Tissue oxygenation

Indexed keywords

ACETYLCYSTEINE; BILIRUBIN; CREATININE; DEETHYLLIDOCAINE; DOPAMINE; ENOXIMONE; FENTANYL; FLUNITRAZEPAM; LACTIC ACID; LIDOCAINE; NORADRENALIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART INDEX; HUMAN; INTENSIVE CARE; LIVER BLOOD FLOW; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; STOMACH MUCOSA; TISSUE OXYGENATION;

EID: 0034517906     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200012000-00006     Document Type: Article

References (65)

1. Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients
2. 2 consumption and the pH value of the gastric mucosa: Indicators of tissue oxygenation
3. Regional blood flow and oxygen transport in septic shock
4. Decreased nutrient blood flow during dopamine- and epinephrine-induced intestinal vasodilation
5. Epinephrine impairs splanchnic perfusion in septic shock
6. Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock
7. Improvement of hepatic microhemodynamics by N-acetylcysteine after warm ischemia
8. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure
9. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double-blind study
10. N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction
11. Decreased hepatic glutathione levels in septic shock: Predisposition of hepatocytes to oxidative stress - An experimental approach
12. Changes in the levels of endogenous antioxidants in the liver of mice with experimental endotoxemia and the protective effects of the antioxidants
13. Pharmacokinetics of N-acetylcysteine in man
14. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid
15. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor
16. Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function
17. Effects of N-acetylcysteine and terbutaline treatment on hemodynamics and regional albumin extravasation in porcine septic shock
18. Haematological, physiological and survival data in a porcine model of adult respiratory distress syndrome induced by endotoxaemia: Effects of treatment with N-acetylcysteine
19. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
20. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients
21. Gastric tonometry in healthy volunteers: Effect of ranitidine on calculated intramural pH
22. 2 is an important source of error in the assessment of gastric intramucosal pH
23. Predictive value of the stomach wall pH for complications after cardiac operations: Comparison with other monitoring
24. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function
25. Indocyanine green: Its use as an early indicator of hepatic dysfunction following injury in man
26. Monoethylglycinexylidide (MEGX) as an early predictor of liver dysfunction in severe sepsis
27. Measuring lignocaine metabolite-monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis
28. Glutathione redox pathway and reperfusion injury: Effect of N-acetylcysteine on infarct size and ventricular function
29. A trial of antioxidants N-acetylcysteine and procysteine in ARDS: The antioxidant in ARDS study group
30. Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis
31. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine
32. The heart in infection and MODS
33. Endotoxin and tumor necrosis factor alpha exert a similar proinflammatory effect in neonatal rat cardiomyocytes, but have different cardiodepressant profiles
34. Protective effects of N-acetyl-L-cysteine in endotoxemia
35. N-acetylcysteine in sepsis
36. Effects of N-acetylcysteine on hepatic blood flow and function
37. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green
38. Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis
39. The estimation of hepatic flow in man
40. Estimation of hepatic blood flow with indocyanine green
41. Effects of hemodilution on splanchnic perfusion and hepatorenal function: I. Splanchnic perfusion
42. Effects of hemodilution on splanchnic perfusion and hepatorenal function: II. Renal perfusion and hepatorenal function
43. 2 dependency exist in critically ill septic patients?
44. The efficacy of N-acetylcysteine as a hepatoprotective agent in liver transplantation
45. Does N-acetylcysteine improve hemodynamics and graft function in liver transplantation?
46. Free radical scavengers to prevent reperfusion injury following experimental warm liver ischaemia: Is there a real physiological benefit?
47. Monitoring the hepato-splanchnic region in the critically ill patient: Measurement techniques and clinical relevance
48. Lignocaine metabolism in human liver microsomes by cytochrome P450IIIA4
49. Hepatocyte heterogeneity: The coming of age from the description of a biological curiosity to a partial understanding of its physiological meaning and regulation
50. Clinical pharmacokinetics of lignocaine
51. Effects of reduced glutathione and N-acetylcysteine on lignocaine metabolism in cimetidine treated rats
52. The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans
53. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine
54. Lidocaine metabolite formation as a measure of pre-transplant liver function
55. Functional state of the donor liver and early outcome of transplantation
56. Monoethylglycinexylidide test: A prognostic indicator of survival in cirrhosis
57. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock
58. Gastric mucosal tonometry: More than splanchnic circulation and oxygenics
59. Gastric mucosal tonometry: Towards new methods and applications
60. 2 during peritonitis and shock
61. 2 as monitor of perfusion failure during hemorrhagic and anaphylactic shock
62. 2 during hemorrhagic shock
63. The application of N-acetylcysteine as an antioxidant and mucolytic in mechanical ventilatory support in intensive care patients: A prospective, randomized, placebo controlled, double-blind study
64. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?
65. Multiple-organ failure: Generalized autodestructive inflammation?